TNF-α Reporter HEK 293 Cells
|HEK-Blue™ TNF-α cells||Unit size||Cat. code||Docs||Qty||Price|
Human TNF-α SEAP Reporter Cells
3-7 x 10e6 cells
TNF-α signaling pathway in HEK-Blue™ TNF-α cells
Human and murine TNF-α Reporter Cells
HEK-Blue™ TNF-α cells enable the detection of bioactive human and murine tumor necrosis factor-alpha (TNF-α) by monitoring the activation of the NF-κB pathway.
TNF-α is a multi-functional pro-inflammatory cytokine involved in the regulation of a wide spectrum of biological processes, such as cell proliferation, differentiation, and apoptosis . Notably, deregulated TNF-α production has been implicated in a variety of conditions, including autoimmune and inflammatory diseases .
Cell line description:
HEK-Blue™ TNF-α cells were generated by stable transfection of human embryonic kidney HEK293 cell line with a SEAP reporter gene under the control of the IFN-β minimal promoter fused to five NF-κB (and five AP-1) binding sites. They were further rendered unresponsive to IL-1β by knocking-out the MyD88 gene. Stimulation of HEK-Blue™ TNF-α cells with TNF-α triggers the activation of the NF-κB-inducible promoter and the production of SEAP.
Levels of SEAP in the supernatant can be easily determined using QUANTI-Blue™ Soultion, a reagent that turns purple/blue in the presence of SEAP, by reading the OD at 620-655 nm.
HEK-Blue™ TNF-α cells are resistant to Puromycin and Zeocin® .
Features of HEK-Blue™ TNF-α cells:
- Fully functional TNF-α signaling pathway
- Do not respond to IL-1β
- Readily assessable SEAP reporter activity
- Functionally tested and guaranteed mycoplasma-free
Applications of HEK-Blue™ TNF-α cells:
- Detection of human TNF-α
- Screening of anti-TNF-α antibodies
1. Sedger L. & McDermott M., 2014. TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future. Cytokine Growth Factor Rev. 25(4):453-72.
Response of HEK-Blue™ TNF-α cells to TNF-α and IL-1β. Cells were incubated with increasing concentrations of human and murine TNF-α and human IL-1β. After a 24h incubation, NF-κB/AP-1 activation was assessed by measuring the levels of SEAP in the supernatant using QUANTI-Blue™ Solution, a SEAP detection reagent, and by reading the optical density (OD) at 655 nm.
Antibiotic resistance: Puromycin, Zeocin®
Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin, 100 µg/ml Normocin™
- Reporter activity is validated by stimulating the cells with human and murine TNF-α.
- The cells are guaranteed mycoplasma-free.
Detects human and murine TNF-α
- hTNF-α EC50: 0.01 ng/ml (in medium) or 0.7 ng/ml (in water)
- mTNF-α EC50: 0.1 ng/ml (in medium) or 3 ng/ml (in water)
This product is covered by a Limited Use License (See Terms and Conditions).Back to the top
- 1 vial of HEK-Blue™ TNF-α cells (3-7 x 10e6 cells)
- 1 ml of Puromycin (10 mg/ml)
- 1 ml of Zeocin® (100 mg/ml)
- 1 ml of Normocin™ (50 mg/ml)
- 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)
Shipped on dry ice (Europe, USA, Canada and some areas in Asia)Back to the top
Tumor necrosis factor-alpha (TNF-α) is a pleiotropic cytokine involved in necrotic and apoptotic cell death, cellular differentiation, inflammation, and regulation of immune cell activity . TNF-α is mainly produced by activated monocytes, macrophages, and T cells. It is first synthesized as a membrane-bound molecule that forms a compact homotrimer through non-covalent interactions. The trimeric membrane-bound form is cleaved by tumor necrosis factor-alpha converting enzyme (TACE) releasing the soluble trimer . Both the membrane-bound and soluble TNF-α bind homotrimeric transmembrane receptors, TNFR1 or TNFR2, triggering signaling pathways that involve TRADD, TRAF2, and RIP, and leading to the activation of NF-κB and MAPK pathways.
Interleukin 1 beta (IL-1β) is another inflammatory cytokine that triggers these pathways following the binding to its receptor IL-1RI and the recruitment of MyD88. Both TNF-α and IL-1β receptors are expressed in HEK293 cells. HEK-Blue™ TNF-α Cells are rendered unresponsive to IL-1β by stable knock-out of the MyD88 gene.
1. Steeland S. et al., 2018. A new venue of TNF targeting. Int. J. Mol. Sci. 19:1442.
2. Brenner D. et al., 2015. Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol. 15(6):362-74.